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Objective—This study examines the impact of Family Healthware™ on communication 
behaviors; specifically, communication with family members and health care providers about 
family health history.
Methods—A total of 3786 participants were enrolled in the Family Healthware™ Impact Trial 
(FHITr) in the United States from 2005-7. The trial employed a two-arm cluster-randomized 
design, with primary care practices serving as the unit of randomization. Using generalized 
estimating equations (GEE), analyses focused on communication behaviors at 6 month follow-up, 
adjusting for age, site and practice clustering.
Results—A significant interaction was observed between study arm and baseline communication 
status for the family communication outcomes (ps<.01), indicating that intervention had effects of 
different magnitude between those already communicating at baseline and those who were not. 
Among participants who were not communicating at baseline, intervention participants had higher 
odds of communicating with family members about family history risk (OR=1.24, p=0.042) and 
actively collecting family history information at follow-up (OR=2.67, p=0.026). Family 
Healthware™ did not have a significant effect on family communication among those already 
communicating at baseline, or on provider communication, regardless of baseline communication 
status. Greater communication was observed among those at increased familial risk for a greater 
number of diseases.
Conclusion—Family Healthware™ prompted more communication about family history with 
family members, among those who were not previously communicating. Efforts are needed to 
identify approaches to encourage greater sharing of family history information, particularly with 
health care providers.
Keywords
family history assessment; family communication; provider communication; dose effects; chronic 
disease
Introduction
Family health history is considered a genomic tool and proxy to genetic predisposition that 
can serve as a means to better guide and personalize medical care and disease prevention 
[1-4]. Family Healthware™, developed by the Centers for Disease Control and Prevention, is 
a self-administered web-based family history tool that assesses familial risk for six common 
chronic conditions and provides personalized prevention messages based on risk [5]. The 
Family Healthware™ Impact Trial (FHITr) set out to examine whether the provision of 
personalized prevention messages, based on family history risk for coronary heart disease, 
stroke, diabetes, and colon, breast and ovarian cancers would result in changes in 
corresponding screening and lifestyle behaviors. Previously reported results from the overall 
trial demonstrated that intervention participants, who completed Family Healthware™ and 
received tailored preventive messages based on family history risk for six conditions (heart 
disease, stroke, diabetes, and colon, breast, and ovarian cancer), were more likely to improve 
in self-reported physical activity and fruit and vegetable intake at follow-up, irrespective of 
risk levels, compared to control participants who received a standard preventive message 
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[6]. Conversely, cancer screening behaviors did not differ across study arms and improved 
over time for all risk groups [7].
In its simplest form, family health history risk information was anticipated to motivate 
lifestyle behavior change through its influence on disease risk perceptions and 
communication behaviors (see conceptual model in Figure 1, based on prior empirical 
evidence and theories of health behavior [8-15]). As previously reported, the provision of 
personalized risk based on family history assessment significantly increased disease risk 
perceptions among those who underestimated their risk at baseline, particularly for the 
metabolic conditions included within the tool [16]. However, an underlying goal behind 
national efforts to promote the collection and documentation of family history is to foster 
greater communication about familial disease with family members and health care 
providers [1, 2]. Prior studies suggest that efforts to increase communication within the 
family may have beneficial outcomes. For example, frequency of health-specific 
communication with family members is directly associated with health behaviors including 
diet and exercise [17]. Moreover, population-based surveys have shown that a positive 
family history is associated with greater discussion of cancer screening and diet and exercise 
recommendations with clinicians, and greater reported rates of screening adherence and 
lifestyle changes among patients [18-20], suggesting that efforts to increase awareness of 
family history might promote health behaviors directly, as well as indirectly via increased 
communication.
To date, few studies have examined whether interventions to increase family history 
awareness and documentation increase the extent to which this information is discussed 
within families or shared with health care providers [21, 22]. As such, the purpose of this 
study was twofold. First, the impact of Family Healthware™ on communication behaviors 
was examined. Specifically, communication about family health history with family 
members and with primary care physicians was examined. Second, this study examined 
whether there were differences in communication outcomes based on the number of diseases 
(i.e. dose effect) for which a person was deemed at elevated risk by the program, as prior 
studies have shown this to correspond with disease risk perceptions [23, 24].
Methods
Participants
A total of 3786 patients were enrolled in the Family Healthware™ Impact Trial (FHITr) 
between 2005-2007, recruited from primary care practices among 13 states in the U.S. 
Participants (aged 35-65) had no prior history of any of the six conditions contained within 
Family Healthware™. They were also ineligible for the trial if they were pregnant or did not 
speak or read English. Of note, two patients were assigned wrongly to the intervention arm 
within a practice site that was designated to be a control site. Their data was excluded from 
further analysis making the final number of analyzable subjects 3784.
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Sample Recruitment and Randomization
The Family Healthware™ Impact Trial employed a two-arm cluster-randomized design, with 
primary care practices serving as the unit of randomization. A total of 41 primary care 
practices, affiliated with one of three academic sites (Evanston Northwestern Healthcare – 
now NorthShore University HealthSystem, University of Michigan, and Case Western 
Reserve University/American Academy of Family Physicians’ National Research Network), 
were recruited to the trial. Site-specific study protocols were approved by the IRBs at each 
of the academic sites, and a combined protocol was approved by the CDC's IRB. 
Participants were identified from practice records according to each site's approved protocol 
and sent letters signed by their primary care physicians inviting them to take part in the trial. 
Randomization to either the intervention or control arm was executed with site-specific 
randomization schemes. Participants at the majority of practices had upcoming appointments 
with a primary care physician, but those affiliated with University of Michigan were 
recruited without regard for a scheduled physician visit. Additional details on study 
recruitment and randomization are provided elsewhere [25]. The study CONSORT diagram 
is presented in Figure 2.
Intervention and Control Arms
Participants in the Family Healthware™ intervention study arm completed an online baseline 
survey followed by the tool, which assessed familial risk and presented personalized 
prevention messages, tailored to familial risk for each of the six conditions. Messages based 
on risk status were focused on the following: weak familial risk – reinforcement of standard 
prevention recommendations; moderate familial risk – provision of personalized prevention 
recommendations; strong familial risk – provision of personalized prevention 
recommendations and referral to specialist. Participants in the control study arm also 
completed the online baseline survey, but were not provided access to the tool until after 
completion of the 6 month follow-up survey. Control messages were general prevention 
messages, not tailored to familial risk, and delivered following completion of the baseline 
survey. Additional details on the Family Healthware™ tool and risk algorithms are available 
elsewhere [5-7]. Samples of both intervention and control arm messages are also available 
online as supplemental information [6].
Study Measures
Familial risk—Risk based on family history was calculated using the Family Healthware™ 
tool, which determined familial risk based on self-reported health history for oneself and 
first/second-degree relatives. A designation of weak, moderate, or strong was made for each 
of the six conditions. A weak family history was indicated when no family history, or late-
onset disease in a single second-degree relative was reported. Moderate familial risk 
included those with a first-degree relative with late-onset disease or two second-degree 
relatives from the same lineage with late onset disease. Strong familial risk included a first-
degree relative with early-onset disease, multiple affected relatives, or indications of a 
hereditary syndrome [5]. For the analyses to examine dose effects, familial risk was 
dichotomized as non-elevated (weak risk) versus elevated (moderate/strong risk) and 
aggregated to create a total number of diseases at elevated risk (ranging from 0-6).
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Communication with family members—Two separate questions were used to assess 
communication with family members, administered at baseline and 6-month follow-up. The 
first item asked, “Have you talked with any of your family members about your family 
health history?” Response options included: “Yes, but more than 6 months ago, Yes, within 
the past 6 months, No, but I intend to in the next 30 days, No, but I intend to in the next 6 
months, and No, and I do not intend to in the next 6 months.” The second communication 
item asked participants, “Have you ever/In the last 6 months, have you actively collected 
health information from your relatives for the purposes of recording a family health 
history?” (yes/no).
Communication with health care providers—A single item was administered at 
baseline and 6-month follow-up that asked respondents “Have you talked with any of your 
health providers about your family health history. Response options included: “Yes, but 
more than 6 months ago, Yes, within the past 6 months, No, but I intend to in the next 30 
days, No, but I intend to in the next 6 months, and No, and I do not intend to in the next 6 
months.”
Analytic plan
Demographic characteristics were compared between study arms using Chi-square and 
independent sample t-tests. Baseline communication status was compared between the study 
arms using Chi-square tests for the three different communication variables. The impact of 
Family Healthware™ and level of familial risk on communication behaviors at follow-up 
was assessed using clustered logistic regression models for each of the communication 
outcomes. For the communication items assessing ‘talking with’ family members or 
providers, an affirmative response on communicating in the past 6 months defined an 
individual as communicating at follow-up, with any other response considered not 
communicating. A generalized estimating equations (GEE) approach with an exchangeable 
working correlation structure was adopted to account for practice clustering. Models 
included experimental arm and number of diseases at elevated risk as the main predictors of 
interest and controlled for age, gender, study site and communication at baseline. 
Communication at baseline was dichotomized into communicating (a response of ‘yes’ to 
the active collection question, or ‘yes, within the past 6 months’ to the family members and 
health care provider communication) or not communicating (any other response). An 
interaction between experimental arm and baseline communication status was also included 
to determine whether the intervention had similar impact between those already 
communicating at baseline and those not communicating at baseline.
Results
Participant Characteristics
Of the 3784 participants whose data were analyzed, 3344 completed the entire protocol 
(Table 1). Participants had a mean age of 50.6 years, with the majority being White (91%), 
female (70%), college educated (72%), married or living with partner (79%), and with a 
reported income greater than $75,000 per year (55%). Based on Family Healthware™ 
assessment, 82% of participants were categorized as having a moderate or strong familial 
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risk for at least one of the six conditions contained within the tool. Significant differences 
were observed between experimental arms with respect to age, gender, and income; the 
control arm had higher average age (p=0.006), more male participants (p=0.034) and a 
greater percentage of individuals in the higher income category (p=0.001), compared with 
the intervention arm. No other demographic differences were observed between groups. 
Although there was a difference in income level across the study arms at baseline, the 
models presented in the article are not adjusted for income primarily due to a high level of 
missing data (457 missing values). Additional analyses adjusting for income were 
conducted, however, results did not differ qualitatively from those presented here (data not 
shown).
Baseline Communication
Table 2 presents baseline levels of family history communication with family members and 
health care providers. Approximately 41.9% of participants had talked to family members 
about their family health history in the last 6 months with an additional 40.6% reporting they 
communicated, but more than 6 months ago. Conversely, only 27.6% of patients reported 
talking about family history with health care providers in the last 6 months, however 62% 
had done so more than 6 months ago. In addition, only 22.8% of participants indicated at 
baseline that they had ever actively collected health information from relatives for the 
purposes of recording a family health history. There were no significant differences across 
study arms in any of the baseline communication variables (all p's>.05).
Impact of Family Healthware™ on Communication Behaviors
Table 3 presents the models examining the impact of Family Healthware™ on 
communication behaviors. Most notably, there was a significant interaction observed 
between study arm and baseline communication status for family member communication 
(p=.006) and active collection outcomes (p=.003), indicating that intervention had effects of 
different magnitudes between those already communicating at baseline and those who were 
not. Among those who were not communicating at baseline, intervention participants were 
significantly more likely to report communication with family members about family history 
(34% vs. 29%, OR=1.24; 95% CI: 1.01-1.53, p=0.042) and active collection family history 
information (13% vs. 5.4%, OR=2.67; 95% CI: 2.01-3.54, p=0.026) at follow-up compared 
to control participants. There was not a significant intervention effect among those who 
were already communicating at baseline on family communication (61% intervention vs. 
65% control, OR=0.82; 95% CI: 0.66-1.02, ns) or active collection (32% intervention vs. 
26% control, OR= 1.26; 95% CI: 0.91-1.75, ns). There was a marginal effect of the 
intervention on communication with health care providers among those not communicating 
at baseline (40% vs. 35%, OR= 1.23; 95% CI: 1.00-1.51, p=.055), but no group differences 
among those already communicating at baseline (49% vs. 46%, OR= 0.92; 95% CI: 
0.70-1.21, ns). The interaction between study arm and baseline provider communication was 
not significant.
Communication with family members and providers did not vary by age or gender, but 
active collection of family history information did. Older participants were less likely to 
collect information (OR=0.97; 95% CI: 0.96-0.98, p<0.001) compared to younger 
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participants. Females had higher odds of collecting family history information at follow-up 
(OR =1.35; 95% CI: 1.09–1.66, p=.006) compared to males. Study site had an impact on all 
three communication measures with communication about or active collection on family 
history being significantly greater at study sites that recruited patients with upcoming 
appointments (Case Western/Evanston), compared to the study site that did not (Michigan, 
see Table 3).
Dose Effects on Communication Behaviors
Communication with family members and health care providers about family history and 
active collection of family history information varied as a function of the “dose” or number 
of diseases a person was deemed at elevated risk for (see Table 3). As dose increased, the 
odds of communication, with both family and health care professionals, and collection of 
family history information at follow-up also increased. The effect of dose did not vary by 
study arm (interaction data not shown).
Discussion
The family health history offers an ideal proxy to assess genomic risk and is the simplest 
applied genomic tool available [26]. National efforts to promote awareness of the 
importance of family history often emphasize the importance of communication and the 
sharing of this information with family members and health care providers, which may serve 
as an intermediary goal towards improved prevention and care [1, 26, 27].
This present study is the first large-scale trial to examine the impact of family history 
assessment on communication with family members and providers. In this study, we found a 
positive effect of family history assessment in prompting discussions and active collection 
about family history with family members, among those not doing so in the 6 months 
preceding study entry. A borderline difference was also noted for provider communication 
among noncommunicators at baseline. These findings support the results from prior studies 
examining the impact of family history interventions, which have also reported a positive 
impact on family communication [28] but not provider communication [21, 22].
Six months after using Family Healthware™, fewer than half of participants in the 
intervention arm reported communicating with their health care providers about their family 
history information, regardless of baseline communication status. The lack of impact of the 
intervention on communication with health care providers may be reflective of several 
issues noted within our trial, including logistics (e.g., did not see a clinician over the 6 
month follow-up period of the study) and the receipt of low familial risk evaluations. Others 
reasons might also include competing demands, clinical routines, and/or patient uncertainty 
about how to communicate with their provider. Prior qualitative research has noted that 
participants were uncertain about how their relatives or providers would react to discussions 
about family history [22], suggesting that there are barriers in communication that may need 
to be addressed to facilitate greater sharing of family history information.
Not surprisingly, our study found that women were more likely to actively collect family 
history information from relatives following familial risk assessment, which is consistent 
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with prior findings examining the collection of family health history [29, 30], as well as 
other studies examining frequency of family history discussions [27]. We previously 
reported that males were less responsive to changing risk perceptions compared with 
females within the FHITr trial [16], which may have also influenced whether they felt any 
further action or communication with family members was warranted following use of the 
tool. These findings also concur with our prior finding that females know more about their 
family histories compared to males [31], perhaps due to a greater propensity to talk with 
family members about family history. In addition, study findings provide a possible 
explanation as to why others have reported greater inaccuracies in the reporting of paternal 
compared to maternal family histories [32, 33], which has implications for the clinical 
validity of family history assessment.
Communication with health care providers at follow-up was more likely at sites that enrolled 
patients with upcoming medical appointments, but did not differ between intervention and 
control groups. This finding suggests that the timing and implementation of family history 
assessment will be an important consideration in efforts to increase clinical use of the 
information [27, 34].
In this study, we found evidence of a dose effect, such that those who were at elevated 
familial risk for more diseases were more likely to report talking with family members and 
providers following receipt of risk information. We examined whether there was a 
significant interaction between dose and experimental arm and found none (data not shown). 
Thus, our results indicate that communication behaviors in general vary as a function of the 
collective disease risk for an individual. Dose of familial risk was previously found to also 
influence disease risk perceptions [23, 24, 35], suggesting that efforts to better understand 
the impact of risk information should take into consideration potential dose effects, 
particularly when risk for multiple diseases is conveyed.
Computerized tools such as Family Healthware™ may help to highlight disease risks among 
family members and facilitate the identification of previously unknown family history, 
which would reduce the chances for risk misclassification due to lack of awareness. Family 
Healthware™ has been available in the past to investigators doing research but never 
publically available. Currently, there are no plans to update Family Healthware™ for release 
to the general public (Muin Khoury, personal communication). Rather, other publically 
available tools such as the US Surgeon General's My Family Health Portrait (https://
familyhistory.hhs.gov/) have undergone recent updates to include risk algorithms for some 
conditions including colorectal cancer [36] and type 2 diabetes and may be used to facilitate 
the collection and sharing of family health history.
This study had several limitations. Study participants were predominately White, well-
educated, and recruited through primary care settings, which may limit the generalizability 
of results to other populations and settings. In addition, although the present study reported 
on the impact of family history assessment on communication behaviors, other concepts 
related to family communication, such as family closeness, cohesion and structure [8, 37], 
were not explored or assessed. This is a limitation in the conceptualization of program 
impact, which focused more on the lifestyle behavioral outcomes. Additional studies 
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examining the role of these and other constructs [27] associated with the sharing of family 
health history are needed. Finally, the communication items used in the trial that focused on 
the timing of communication (i.e., “yes, within the last 6 months” or “yes, more than 6 
months ago”) presented challenges in the interpretation of the tool's communication impact, 
since individuals endorsing “yes, but more than 6 months ago) may have communicated 
years ago and may not have engaged in new communication during the trial timeframe. As 
such, our analyses defined only those who indicated “yes, within the past 6 months” as 
having communicated, both at baseline and follow-up, in efforts to best capture individuals 
who may have been prompted to communicate during the trial period.
Conclusion
Family Healthware™ prompted more communication about family history with family 
members, particularly among those who were not previously communicating. Efforts are 
needed to understand potential reasons for not communicating and identify approaches to 
encourage greater sharing of family health history information, particularly with health care 
providers.
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Figure 1. 
Conceptual Model
Wang et al. Page 12
Prev Med. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
Consort Diagram
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Table 1
Demographics
Intervention Arm (N = 2362) Control Arm (N = 1422) Total (N=3784)
Age, Years (Mean)a 50.3 (8.4) 51.1 (8.0) 50.6 (8.2)
Gender, Femaleb 1675 (71%) 962 (68%) 2637 (70%)
Race
    Caucasian 2132 (90%) 1320 (93%) 3452 (91%)
    African American 87 (4%) 35 (3%) 122 (3%)
    Asian 70 (3%) 31 (2%) 101 (3%)
Hispanic or Latino 58 (3%) 29 (2%) 87 (2%)
Education (college degree or greater) 1698 (72%) 1025 (72%) 2723 (72%)
Married/Living with Partner 1855 (79%) 1135 (80%) 2990 (79%)
Household Income (>75,000)c 1261 (61%) 834 (66%) 2095 (55%)
Smoker - Current 185 (8%) 108 (8%) 293 (8%)
Family History (Moderate or Strong) N = 2328d N = 1255d N=3784d
    Heart Disease 1381 (59%) 753 (60%) 2134 (60%)
    Stroke 1117 (48%) 615 (49%) 1732 (48%)
    Diabetes 903 (39%) 443 (35%) 1346 (38%)
    Colon Cancer 315 (14%) 186 (15%) 501 (14%)
    Breast Cancer 530 (23%) 265 (21%) 795 (22%)
    Ovarian Cancer 222 (10%) 120 (10%) 342 (10%)
Number of Diseases at Elevated Risk
    0 420 (18.0) 233 (18.6) 653 (18.2)
    1 525 (22.6) 300 (23.9) 825 (23.0)
    2 568 (24.4) 286 (22.8) 854 (23.8)
    3 530 (22.8) 281 (22.4) 811 (22.6)
    4 221 (9.5) 120 (9.6) 341 (9.5)
    5 51 (2.2) 23 (1.8) 74 (2.1)
    6 13 (0.6) 12 (1.0) 25 (0.7)
ap=0.006
bp=0.034
cp=0.001
dSample size excludes participants without complete family history data
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Table 2
Communication with family members and health care providers, baseline, N (%)
Intervention Arm (N=2362) Control Arm (N=1422) Total (N=3784)
Have you talked to any of your family members about 
your family health history?
    No* 411 (17.4) 254 (17.9) 665 (17.6)
    Yes, within the last 6 months 1008 (42.7) 576 (40.5) 1584 (41.9)
    Yes, but more than 6 months ago 943 (39.9) 592 (41.6) 1535 (40.6)
Have you talked to any of your medical providers about 
your family health history?
    No* 278 (11.8) 151 (10.6) 429 (11.3)
    Yes, within the last 6 months 653 (27.6) 390 (27.4) 1043 (27.6)
    Yes, but more than 6 months ago 1431 (60.6) 881 (62.0) 2312 (61.1)
Have you ever actively collected health information from 
your relatives for the purposes of recording a family health 
history?
    No 1819 (77.0) 1101 (77.4) 2920 (77.2)
    Yes 543 (23.0) 321 (22.6) 864 (22.8)
*No responses are combined for this item and include the following: No, but I intend to in the next 30 days, No, but I intend to in the next 6 
months, and No, and I do not intend to in the next 6 months.
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Table 3
Impact of Family Healthware™ on family history communication behaviors at follow-up, OR (95% CI)a
Predictors Family Members N=3344b Health Care Providers 
N=3344b
Active Collection (from 
family) N=3344b
Age 1.00 (0.99, 1.01) 0.99 (0.98, 1.01) 0.97 (0.96, 0.98)
Gender
    Male Ref Ref Ref
    Female 1.15 (0.99, 1.33) 1.07 (0.91, 1.26) 1.35 (1.09, 1.66)
Site
    Michigan Ref Ref Ref
    Case Western 1.24 (0.96, 1.60) 1.68 (1.26, 2.24) 1.35 (1.05, 1.75)
    Evanston 1.44 (1.21, 1.71) 1.71 (1.41, 2.07) 1.30 (1.16, 1.46)
Baseline Communication Statusc
    Not Communicating Ref Ref Ref
    Communicating 4.56 (3.68, 5.66)d 1.68 (1.43, 1.99)d 6.26 (4.10, 9.56)d
Experimental Arm
    Control Ref Ref Ref
    Intervention 1.24 (1.01, 1.53)e 1.23 (1.00, 1.51)e 2.67 (2.01, 3.54)e
Dose 1.15 (1.09, 1.22) 1.12 (1.06, 1.18) 1.15 (1.08, 1.24)
Baseline Communication * Experimental 
Arm
0.66 (0.49, 0.89) 0.89 (0.69, 1.14) 0.47 (0.29, 0.78)
aCommunication at follow-up was a dichotomized outcome. Active collection was assessed using a yes/no response. The other communication 
items were dichotomized as yes (yes, within the past 6 months) or no (all other responses).
bSample includes participants with valid communication data at both baseline and follow-up.
cNot communicating at baseline included those who responded any form of 'no' or 'yes but more than 6 months ago' and communicating at baseline 
included those who responded 'yes' for Active Collection or 'yes, within the last 6 months' for family member and health care provider 
communication.
dORs and CIs for control arm.
eORs and CIs for non-communicators at baseline.
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